Skip to main content

letter

. 1993 Apr 24;306(6885):1125. doi: 10.1136/bmj.306.6885.1125-b

Effective and acceptable treatment for depression.

PMCID: PMC1677542 PMID: 8495169

1125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Beasley C. M., Jr, Dornseif B. E., Pultz J. A., Bosomworth J. C., Sayler M. E. Fluoxetine versus trazodone: efficacy and activating-sedating effects. J Clin Psychiatry. 1991 Jul;52(7):294–299. [PubMed] [Google Scholar]
Henry J. A. Toxicity of antidepressants: comparisons with fluoxetine. Int Clin Psychopharmacol. 1992 Jun;6 (Suppl 6):22–27. [PubMed] [Google Scholar]
Noguera R., Altuna R., Alvarez E., Ayuso J. L., Casais L., Udina C. Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial. J Affect Disord. 1991 Jul;22(3):119–124. doi: 10.1016/0165-0327(91)90045-t. [DOI] [PubMed] [Google Scholar]
Song F., Freemantle N., Sheldon T. A., House A., Watson P., Long A., Mason J. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ. 1993 Mar 13;306(6879):683–687. doi: 10.1136/bmj.306.6879.683. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES